January 23, 2025

Pre-clinical therapy studies for rare diseases using small molecules and biologicals – development and validation

Pre-clinical therapy studies for rare diseases using small molecules and biologicals – development and validation
Go back

Our latest News

discover more
GalaTek GmbH and a:head bio AG Announce Strategic Collaboration to Automate Human Brain Organoid Workflows

GalaTek GmbH and a:head bio AG Announce Strategic Collaboration to Automate Human Brain Organoid Workflows

Vienna, Austria – October 22, 2025 – GalaTek GmbH, a leading innovator in laboratory automation technologies, and a:head bio AG, a pioneering biotech company specializing in human brain organoid research, today announced a strategic collaboration aimed at advancing the automation of brain organoid workflows. The partnership aims to integrate GalaTek’s advanced robotics and software platforms with […]

read more
Clean Tech Innovation Day & Solar TAP Industry Day: Advanced solutions are needed

Clean Tech Innovation Day & Solar TAP Industry Day: Advanced solutions are needed

Heidelberg, Germany, October 22, 2025 – It’s all about a sustainable, smarter energy future: Clean Tech Innovation Day & Solar TAP Industry Day showed that this can only be achieved with a shared mission and vision. More than 70 participants from science, industry, and start-ups took the opportunity at the Heidelberg Congress Center to exchange […]

read more
Sanofi’s Wayrilz recommended for EU approval by the CHMP to treat immune thrombocytopenia

Sanofi’s Wayrilz recommended for EU approval by the CHMP to treat immune thrombocytopenia

Sanofi’s Wayrilz recommended for EU approval by the CHMP to treat immune thrombocytopenia Paris, October 17, 2025. The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the approval of Wayrilz (rilzabrutinib) as a new treatment for immune thrombocytopenia (ITP) in adult patients who are refractory to other […]

read more

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp